Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 62, Issue 16, Pages 1814-1825Publisher
SPRINGER BASEL AG
DOI: 10.1007/s00018-005-5092-5
Keywords
familial British dementia; familial Danish dementia; congophilic amyloid angiopathy; ABri; ADan; cerebral amyloidosis; amyloid beta; Alzheimer's disease
Categories
Funding
- NIA NIH HHS [AG05891, AG08721] Funding Source: Medline
- NINDS NIH HHS [NS38777] Funding Source: Medline
Ask authors/readers for more resources
The importance of cerebral amyloid deposition in the mechanism of neurodegeneration is still debatable. Classic arguments are usually centered on amyloid beta (A beta) and its role in the neuronal loss characteristic of Alzheimer's disease, the most common form of human cerebral amyloidosis. Two non-A beta cerebral amyloidoses, familial British and Danish dementias (FBD and FDD), share many aspects of Alzheimer's disease, including the presence of neurofibrillary tangles, parenchymal preamyloid and amyloid deposits, cerebral amyloid angiopathy and a variety of amyloid-associated proteins and inflammatory components. Both early-onset conditions are linked to specific mutations at or near the stop codon of the chromosome 13 gene BRI2 that cause generation of longer-than-normal protein products. Furin-like processing of these longer precursors releases two de novo-created peptides, ABri and ADan, which deposit as amyloid fibrils in FBD and FDD, respectively. Due to the similar pathology generated by completely unrelated amyloid subunits, FBD and FDD, collectively referred to as chromosome 13 dementias, constitute alternative models for studying the role of amyloid deposition in the mechanism of neuronal cell death.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available